Department of Health and Human Services May 17, 2023 – Federal Register Recent Federal Regulation Documents
Results 1 - 8 of 8
Cheese Products Deviating From Identity Standard; Temporary Permit for Market Testing
The Food and Drug Administration (FDA or we) is announcing the extension of a temporary permit issued to Bongards Creameries (the applicant) to market test several pasteurized standardized cheeses that deviate from the U.S. standards of identity for cheese products. The extension allows the applicant to continue to evaluate commercial viability of the products and to collect data on consumer acceptance of the products, in support of a petition to amend the standard of identity for cheese products. We also invite other interested parties to participate in the market test.
Government-Owned Inventions; Availability for Licensing
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Submission for OMB Review; Office of Refugee Resettlement Unaccompanied Refugee Minors Program Application and Withdrawal of Application or Declination of Placement Form (OMB #0970-0550)
The Office of Refugee Resettlement (ORR) is requesting a 3- year extension with revisions of the Unaccompanied Refugee Minors (URM) Program Application and Withdrawal of Application or Declination of Placement Form (OMB #0970-0550, expiration 08/31/2023). Proposed revisions include additional instructions, a small number of new questions, dropping a few questions, and rephrasing existing questions.
Compliance Policy Guide Sec. 555.250 Major Food Allergen Labeling and Cross-Contact; Availability
The Food and Drug Administration (FDA or we) is announcing the availability of a draft Compliance Policy Guide entitled ``Sec. 555.250 Major Food Allergen Labeling and Cross-contact.'' The draft guidance, when finalized, will replace existing guidance for FDA staff on FDA's enforcement policy regarding major food allergen labeling and cross- contact.
Meeting of the Advisory Committee on Blood and Tissue Safety and Availability
The U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will hold a meeting. The meeting will be open to the public via webcast. The committee will discuss and vote on a recommendation related to surge capacity for blood and blood products.
Agency Information Collection Request; 60-Day Public Comment Request
In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.